
### [DOID:201](http://purl.obolibrary.org/obo/DOID_201)
**Label:** connective tissue cancer

**Subclasses:** [DOID:3369](http://purl.obolibrary.org/obo/DOID_3369) (Ewing sarcoma), [DOID:3347](http://purl.obolibrary.org/obo/DOID_3347) (osteosarcoma), [DOID:5485](http://purl.obolibrary.org/obo/DOID_5485) (synovial sarcoma), [DOID:2775](http://purl.obolibrary.org/obo/DOID_2775) (long bone adamantinoma), [DOID:3371](http://purl.obolibrary.org/obo/DOID_3371) (chondrosarcoma), [DOID:5363](http://purl.obolibrary.org/obo/DOID_5363) (myxoid liposarcoma), 

**Corr. equiv. classes:** [OMIM:613488](http://purl.obolibrary.org/obo/OMIM_613488), [OMIM:612219](http://purl.obolibrary.org/obo/OMIM_612219), [OMIM:215300](http://purl.obolibrary.org/obo/OMIM_215300), [OMIM:300813](http://purl.obolibrary.org/obo/OMIM_300813), [OMIM:259500](http://purl.obolibrary.org/obo/OMIM_259500), [OMIM:102660](http://purl.obolibrary.org/obo/OMIM_102660), 

**Class expressions from DL-Learner:**

- [HP:0100242](http://purl.obolibrary.org/obo/HP_0100242) (Sarcoma) and (not ([HP:0007902](http://purl.obolibrary.org/obo/HP_0007902) (Vitreous hemorrhage))) 74.16%
- [HP:0100242](http://purl.obolibrary.org/obo/HP_0100242) (Sarcoma) and (not ([HP:0007862](http://purl.obolibrary.org/obo/HP_0007862) (Retinal calcification))) 74.16%
- [HP:0100242](http://purl.obolibrary.org/obo/HP_0100242) (Sarcoma) and (not ([HP:0006743](http://purl.obolibrary.org/obo/HP_0006743) (Embryonal rhabdomyosarcoma))) 74.16%
- [HP:0100242](http://purl.obolibrary.org/obo/HP_0100242) (Sarcoma) and (not ([HP:0006740](http://purl.obolibrary.org/obo/HP_0006740) (Transitional cell carcinoma of the bladder))) 74.16%
- [HP:0100242](http://purl.obolibrary.org/obo/HP_0100242) (Sarcoma) and (not ([HP:0006716](http://purl.obolibrary.org/obo/HP_0006716) (Hereditary nonpolyposis colorectal carcinoma))) 74.16%
- [HP:0100242](http://purl.obolibrary.org/obo/HP_0100242) (Sarcoma) and (not ([HP:0004327](http://purl.obolibrary.org/obo/HP_0004327) (Abnormality of the vitreous humor))) 74.16%
- [HP:0100242](http://purl.obolibrary.org/obo/HP_0100242) (Sarcoma) and (not ([HP:0003745](http://purl.obolibrary.org/obo/HP_0003745) (Sporadic))) 74.16%
- [HP:0100242](http://purl.obolibrary.org/obo/HP_0100242) (Sarcoma) and (not ([HP:0002891](http://purl.obolibrary.org/obo/HP_0002891) (Uterine leiomyosarcoma))) 74.16%
- [HP:0100242](http://purl.obolibrary.org/obo/HP_0100242) (Sarcoma) and (not ([HP:0000555](http://purl.obolibrary.org/obo/HP_0000555) (Leukocoria))) 74.16%
- [HP:0100242](http://purl.obolibrary.org/obo/HP_0100242) (Sarcoma) 71.13%
- [HP:0100242](http://purl.obolibrary.org/obo/HP_0100242) (Sarcoma) and (not ([HP:0000013](http://purl.obolibrary.org/obo/HP_0000013) (Hypoplasia of the uterus))) 71.13%
- [HP:0100242](http://purl.obolibrary.org/obo/HP_0100242) (Sarcoma) and (not ([HP:0000012](http://purl.obolibrary.org/obo/HP_0000012) (Urinary urgency))) 71.13%
- [HP:0100242](http://purl.obolibrary.org/obo/HP_0100242) (Sarcoma) and (not ([HP:0000011](http://purl.obolibrary.org/obo/HP_0000011) (Neurogenic bladder))) 71.13%
- [HP:0100242](http://purl.obolibrary.org/obo/HP_0100242) (Sarcoma) and (not ([HP:0000004](http://purl.obolibrary.org/obo/HP_0000004) (null))) 71.13%
- [HP:0100242](http://purl.obolibrary.org/obo/HP_0100242) (Sarcoma) and (not ([HP:0000003](http://purl.obolibrary.org/obo/HP_0000003) (Multicystic kidney dysplasia))) 71.13%


